AZLI

DRUG7 trials

Sponsors

Gilead Sciences

Conditions

BronchiectasisBurkholderia InfectionsCystic FibrosisPseudomonas AeruginosaPseudomonas Aeruginosa Respiratory Tract Infection/Colonization

Phase 2

Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis

CompletedNCT00805025

Gilead SciencesBronchiectasis

Start: 2008-12-31End: 2009-10-31Updated: 2014-03-20

Phase 3

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection

CompletedNCT01059565

Gilead SciencesBurkholderia Infections, Cystic Fibrosis

Start: 2010-02-28End: 2012-01-31Updated: 2014-03-11

Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis

CompletedNCT01313624

Gilead SciencesBronchiectasis

Start: 2011-04-30End: 2013-06-30Updated: 2014-04-16

Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis

CompletedNCT01314716

Gilead SciencesBronchiectasis

Start: 2011-04-30End: 2013-07-31Updated: 2014-04-16

Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways

CompletedNCT01404234

Gilead SciencesCystic Fibrosis, Pseudomonas Aeruginosa

Start: 2011-12-31End: 2013-04-30Updated: 2014-05-29

Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF

CompletedNCT01641822

Gilead SciencesCystic Fibrosis

Start: 2012-12-31End: 2015-01-31Updated: 2016-05-09

Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria

TerminatedNCT03219164

Gilead SciencesCystic Fibrosis, Pseudomonas Aeruginosa Respiratory Tract Infection/Colonization

Start: 2017-11-28End: 2021-09-23Updated: 2022-06-14

Related Papers

ALPINE2: Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosis

Journal of Cystic Fibrosis2023-07-153 citations

Continuous alternating inhaled antibiotics for chronic pseudomonal infection in cystic fibrosis.

2016-05-2436 citations

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.

2014-08-18158 citations

A preliminary quality of life questionnaire-bronchiectasis: a patient-reported outcome measure for bronchiectasis.

2014-08-0167 citations